HomeNewscoronavirusHow Omicron, the New COVID-19 Variant, Got Its Name

How Omicron, the New COVID-19 Variant, Got Its Name

The practice of naming viruses for regions has also historically been misleading. Ebola, for example, is named for a river that’s actually far from where the virus emerged.

November 28, 2021 / 19:39 IST
Story continues below Advertisement
(Representative image: Reuters)
(Representative image: Reuters)

Markets plunged Friday, hope of taming the coronavirus dimmed and a new term entered the pandemic lexicon: omicron.

The COVID-19 variant that emerged in South Africa was named after the 15th letter of the Greek alphabet.

Story continues below Advertisement

The naming system, announced by the World Health Organization in May, makes public communication about variants easier and less confusing, the agency and experts said.

For example, the variant that emerged in India is not popularly known as B.1.617.2. Rather, it is known as delta, the fourth letter of the Greek alphabet.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show